KIMBERLY BURROW: Open Payments
NPI 1689976193 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,656 in 93 payments from 13 companies in 2025. Trend: 2023 $1,184 · 2024 $1,221 · 2025 $1,656
Food & beverage: $1,656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $441 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $331 |
| Ardelyx, Inc. | 14 | $219 |
| Madrigal Pharmaceuticals | 6 | $171 |
| Janssen Biotech, Inc. | 5 | $127 |
| Phathom Pharmaceuticals, Inc. | 9 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Gilead Sciences, Inc. | 3 | $65 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
| Organon LLC | 2 | $22 |
Products named: XIFAXAN, RINVOQ, IBSRELA, REZDIFFRA, TREMFYA, VOQUEZNA, MAVYRET, ENTYVIO.
Industry payments across KY — which companies pay providers there.
